Recombinant TIGIT antibody

Catalog No. ABIN7826043

This anti-TIGIT antibody is a Mouse Monoclonal antibody detecting TIGIT in FACS and ELISA. Suitable for Mouse.

Quick Overview for Recombinant TIGIT antibody (ABIN7826043)

Target: TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))

Antibody Type: Recombinant Antibody

Reactivity: Mouse

Host: Mouse

Clonality: Monoclonal

Conjugate: This TIGIT antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA

Grade: In vivo Grade

Clone: 10A7

Product Details anti-TIGIT Antibody

Expression System: CHO Cells

Purpose: TIGIT recombinant monoclonal antibody, clone 1F4 targeting mouse TIGIT recombinant protein.

Cross-Reactivity: Mouse

Characteristics: In Vivo Functional Grade Antibodies are optimized for mouse and rat studies, ensuring safety and accuracy in live animal experiments. Each antibody is highly purified and validated by flow cytometry using positive and negative control cell lines. The collection includes mouse-target and human-target antibodies suitable for syngeneic and xenograft tumor models, supporting robust preclinical immunotherapy research

Purification: Protein A purified

Purity: > 95 % by SDS-PAGE under reducing conditions.

Sterility: 0.2 μm filtered

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method.

Immunogen: Mouse TIGIT recombinant protein

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: ≥ 3 μg/μL

Buffer: PBS pH 7.4 with no stabilizers or preservatives added

Preservative: Without preservative

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot to avoid repeated freezing and thawing.

Expiry Date: 12 months

Target Details for TIGIT

Target: TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))

Alternative Name: Tigit

Background:

Gene description: T cell immunoreceptor with Ig and ITIM domains

Gene alias: ENSMUSG00000071552, Vstm3

Gene ID: 100043314

Pathways: Cancer Immune Checkpoints